- Home
- IMMP vs FRGE Comparison
IMMP vs FRGE Comparison
Compare IMMP & FRGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- FRGE
- Stock Information
- Founded
- IMMP 1987
- FRGE 2014
- Country
- IMMP Australia
- FRGE United States
- Employees
- IMMP N/A
- FRGE N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- FRGE Computer Software: Prepackaged Software
- Sector
- IMMP Health Care
- FRGE Technology
- Exchange
- IMMP Nasdaq
- FRGE Nasdaq
- Market Cap
- IMMP 211.1M
- FRGE 172.2M
- IPO Year
- IMMP N/A
- FRGE N/A
- Fundamental
- Price
- IMMP $1.89
- FRGE $17.77
- Analyst Decision
- IMMP Buy
- FRGE Buy
- Analyst Count
- IMMP 2
- FRGE 4
- Target Price
- IMMP $8.50
- FRGE $45.00
- AVG Volume (30 Days)
- IMMP 659.8K
- FRGE 265.8K
- Earning Date
- IMMP 05-23-2025
- FRGE 05-07-2025
- Dividend Yield
- IMMP N/A
- FRGE N/A
- EPS Growth
- IMMP N/A
- FRGE N/A
- EPS
- IMMP N/A
- FRGE N/A
- Revenue
- IMMP $3,019,249.00
- FRGE $85,383,000.00
- Revenue This Year
- IMMP $50.37
- FRGE $19.78
- Revenue Next Year
- IMMP N/A
- FRGE $28.96
- P/E Ratio
- IMMP N/A
- FRGE N/A
- Revenue Growth
- IMMP 24.11
- FRGE 16.04
- 52 Week Low
- IMMP $1.32
- FRGE $6.60
- 52 Week High
- IMMP $3.34
- FRGE $29.85
- Technical
- Relative Strength Index (RSI)
- IMMP 54.39
- FRGE 70.85
- Support Level
- IMMP $1.78
- FRGE $11.88
- Resistance Level
- IMMP $2.71
- FRGE $14.53
- Average True Range (ATR)
- IMMP 0.17
- FRGE 1.33
- MACD
- IMMP 0.02
- FRGE 0.34
- Stochastic Oscillator
- IMMP 25.45
- FRGE 97.36
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About FRGE Forge Global Holdings Inc.
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.